As of Oct 27, 2026. Rebuilt every trading night.
The largest genomics ETFs
See 4 funds ranked by net assets. Updated Oct 27, 2026. Every fund here is sold on genomics. The column beside the size shows how much of each the S&P 500 already holds.
Ask IQ about this page
Ask IQ about the largest genomics ETFsAll 4, highest first
4 of 4 · click a column to sort| # | Ticker | Fund | Net assets ↓ | Weight in S&P 500 companies | Total return, 1Y | Fee | Source |
|---|---|---|---|---|---|---|---|
| 1 | ARKG | ARK Genomic Revolution ETF | $2.1bn, off scale | 4.1% | +65.8% | 0.75% | Issuer holdings, Oct 26, 2026 |
| 2 | IDNA | iShares Genomics Immunology and Healthca | $321m | 25.5% | +66.8% | 0.47% | Issuer daily, Oct 26, 2026 |
| 3 | GNOM | Global X Genomics & Biotechnology ETF | $104m | 17.9% | +56.6% | 0.50% | Issuer page, Oct 12, 2026 |
| 4 | GNMX | Corgi Genomics & Precision Medicine ETF | $1.3m | 28.2% | too new | 0.35% | Issuer daily, Oct 27, 2026 |
The 4 ETFs in the genomics and gene editing theme, of which 4 publish net assets, ranked on the most recent number for each.
The rest of the method
Across the funds listed here the weight held in S&P 500 companies runs from 4.1% to 28.2%. Size shows where the money is, not what a fund did. The list sorts one published number, with no scoring or weighting. Every fund ETFIQ covers in this category is eligible, closed funds included.
Links are sources, not endorsements. A ranking is not a recommendation or an opinion.
Cite this pageCitation, APA and Markdown
ETFIQ, The largest genomics ETFs, ranked by net assets, data as of Oct 27, 2026. https://etfiq.com/rankings/themes-largest-genomics
ETFIQ. (Oct 27, 2026). The largest genomics ETFs, ranked by net assets. Retrieved from https://etfiq.com/rankings/themes-largest-genomics
[The largest genomics ETFs, ranked by net assets (ETFIQ, Oct 27, 2026)](https://etfiq.com/rankings/themes-largest-genomics)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.